Phase 1 Evaluation of the Impact of Coitus on Pharmacokinetics and Pharmacodynamics of Tenofovir 1% Gel Following Pericoital or Daily Gel Dosing

Trial Profile

Phase 1 Evaluation of the Impact of Coitus on Pharmacokinetics and Pharmacodynamics of Tenofovir 1% Gel Following Pericoital or Daily Gel Dosing

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Feb 2017

At a glance

  • Drugs Tenofovir (Primary)
  • Indications HIV infections
  • Focus Biomarker; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 16 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 11 Apr 2014 Planned End Date changed from 1 Apr 2015 to 1 Sep 2014 as reported by ClinicalTrials.gov.
    • 19 Mar 2013 Planned End Date 1 Apr 2015 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top